MI Arrowhead Publishers and Conferences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 4:147-156, (2004)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.4.3.4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, S. H.
Right arrow Articles by Olden, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, S. H.
Right arrow Articles by Olden, K.
Review

The Environmental Genome Project

Phase I and Beyond

Samuel H. Wilson and Kenneth Olden

National Institute of Environmental Health Sciences, National Institutes of Health, 111 T.W. Alexander Drive Research Triangle Park, NC 27709-2233

Correspondence: Address correspondence to SHW. E-mail wilson5{at}niehs.nih.gov; fax 919-541-3592.


Human illness is caused by many interrelated factors including aging, inherited genetic predispositions, and a variety of environmental exposures. There is increasing awareness of the role of genetics as a factor that can dramatically alter susceptibility to all disease, especially environmentally induced chronic disease, such as cancer, asthma, diabetes, cardiovascular disease, and neurodegenerative disorders. In some cases, a genetic factor influences disease susceptibility in a small fraction of the population because it occurs at a low frequency or involves a relatively low-incidence disease; however, in other cases, a genetic factor increases susceptibility in a large number of individuals and involves a disease that occurs at high incidence, creating a large public health burden.




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
S. K. Iyengar
The Quest for Genes Causing Complex Traits in Ocular Medicine: Successes, Interpretations, and Challenges
Arch Ophthalmol, January 1, 2007; 125(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
T. Kreiner and K. T. Buck
Moving toward whole-genome analysis: A technology perspective
Am. J. Health Syst. Pharm., February 1, 2005; 62(3): 296 - 305.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.